Cargando…
Elevated progesterone on the trigger day does not impair the outcome of Human Menotrophins Gonadotrophin and Medroxyprogesterone acetate treatment cycles
To demonstrate the incidence and effects of elevated progesterone (P) on the trigger day on the outcome of in-vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) cycles using Medroxyprogesterone acetate (MPA) co-treated with Human Menotrophins Gonadotrophin (hMG + MPA), we performed a...
Autores principales: | Lu, Xuefeng, Chen, Qiuju, Fu, Yonglun, Ai, Ai, Lyu, Qifeng, Kuang, Yan Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976389/ https://www.ncbi.nlm.nih.gov/pubmed/27498612 http://dx.doi.org/10.1038/srep31112 |
Ejemplares similares
-
Elevated basal luteinizing hormone does not impair the outcome of human menopausal gonadotropin and medroxyprogesterone acetate treatment cycles
por: Sun, Lihua, et al.
Publicado: (2018) -
Use of medroxyprogesterone acetate in women with ovarian endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization
por: Guo, Haiyan, et al.
Publicado: (2017) -
The role of combining medroxyprogesterone 17-acetate with human menopausal gonadotropin in mouse ovarian follicular development
por: Wen, Xiaowei, et al.
Publicado: (2018) -
The effect of human chorionic gonadotrophin contained in human menopausal gonadotropin on the clinical outcomes during progestin-primed ovarian stimulation
por: Zhu, Xiuxian, et al.
Publicado: (2017) -
Menotrophin Induced Autoimmune Hepatitis
por: Alqrinawi, Shurouq H., et al.
Publicado: (2019)